Global Glioblastoma Multiforme Treatment Market Size, Status and Forecast 2025

March 2018 | 90 pages | ID: G388C1B23A0EN
QYResearch

Abstracts

This report studies the global Glioblastoma Multiforme Treatment market, analyzes and researches the Glioblastoma Multiforme Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• AbbVie, Inc
• Activartis GmbH
• Agenus Inc
• Arog Pharmaceuticals, Inc
• Bristol-Myers Squibb Company
• Cavion LLC
• Celldex Therapeutics Inc
• Cortice Biosciences
• Exelixis Inc
• F. Hoffmann-La Roche Ltd.

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into

• Bevacizumab (Avastin)
• Carmustine (BiCNU)
• Temozolomide (Temodar and Temodal and Temcad)

Market segment by Application, Glioblastoma Multiforme Treatment can be split into

• Hospital
• Clinic
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Glioblastoma Multiforme Treatment Market Size, Status and Forecast 2025

1 INDUSTRY OVERVIEW OF GLIOBLASTOMA MULTIFORME TREATMENT

1.1 Glioblastoma Multiforme Treatment Market Overview
  1.1.1 Glioblastoma Multiforme Treatment Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Glioblastoma Multiforme Treatment Market Size and Analysis by Regions (2013-2018)
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Glioblastoma Multiforme Treatment Market by Type
  1.3.1 Bevacizumab (Avastin)
  1.3.2 Carmustine (BiCNU)
  1.3.3 Temozolomide (Temodar and Temodal and Temcad)
1.4 Glioblastoma Multiforme Treatment Market by End Users/Application
  1.4.1 Hospital
  1.4.2 Clinic
  1.4.3 Others

2 GLOBAL GLIOBLASTOMA MULTIFORME TREATMENT COMPETITION ANALYSIS BY PLAYERS

2.1 Glioblastoma Multiforme Treatment Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 AbbVie, Inc
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Glioblastoma Multiforme Treatment Revenue (Million USD) (2013-2018)
  3.1.5 Recent Developments
3.2 Activartis GmbH
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Glioblastoma Multiforme Treatment Revenue (Million USD) (2013-2018)
  3.2.5 Recent Developments
3.3 Agenus Inc
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Glioblastoma Multiforme Treatment Revenue (Million USD) (2013-2018)
  3.3.5 Recent Developments
3.4 Arog Pharmaceuticals, Inc
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Glioblastoma Multiforme Treatment Revenue (Million USD) (2013-2018)
  3.4.5 Recent Developments
3.5 Bristol-Myers Squibb Company
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Glioblastoma Multiforme Treatment Revenue (Million USD) (2013-2018)
  3.5.5 Recent Developments
3.6 Cavion LLC
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Glioblastoma Multiforme Treatment Revenue (Million USD) (2013-2018)
  3.6.5 Recent Developments
3.7 Celldex Therapeutics Inc
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Glioblastoma Multiforme Treatment Revenue (Million USD) (2013-2018)
  3.7.5 Recent Developments
3.8 Cortice Biosciences
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Glioblastoma Multiforme Treatment Revenue (Million USD) (2013-2018)
  3.8.5 Recent Developments
3.9 Exelixis Inc
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Glioblastoma Multiforme Treatment Revenue (Million USD) (2013-2018)
  3.9.5 Recent Developments
3.10 F. Hoffmann-La Roche Ltd.
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Glioblastoma Multiforme Treatment Revenue (Million USD) (2013-2018)
  3.10.5 Recent Developments

4 GLOBAL GLIOBLASTOMA MULTIFORME TREATMENT MARKET SIZE BY TYPE AND APPLICATION (2013-2018)

4.1 Global Glioblastoma Multiforme Treatment Market Size by Type (2013-2018)
4.2 Global Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)
4.3 Potential Application of Glioblastoma Multiforme Treatment in Future
4.4 Top Consumer/End Users of Glioblastoma Multiforme Treatment

5 UNITED STATES GLIOBLASTOMA MULTIFORME TREATMENT DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Glioblastoma Multiforme Treatment Market Size (2013-2018)
5.2 United States Glioblastoma Multiforme Treatment Market Size and Market Share by Players (2013-2018)
5.3 United States Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)

6 EU GLIOBLASTOMA MULTIFORME TREATMENT DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Glioblastoma Multiforme Treatment Market Size (2013-2018)
6.2 EU Glioblastoma Multiforme Treatment Market Size and Market Share by Players (2013-2018)
6.3 EU Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)

7 JAPAN GLIOBLASTOMA MULTIFORME TREATMENT DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Glioblastoma Multiforme Treatment Market Size (2013-2018)
7.2 Japan Glioblastoma Multiforme Treatment Market Size and Market Share by Players (2013-2018)
7.3 Japan Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)

8 CHINA GLIOBLASTOMA MULTIFORME TREATMENT DEVELOPMENT STATUS AND OUTLOOK

8.1 China Glioblastoma Multiforme Treatment Market Size (2013-2018)
8.2 China Glioblastoma Multiforme Treatment Market Size and Market Share by Players (2013-2018)
8.3 China Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)

9 INDIA GLIOBLASTOMA MULTIFORME TREATMENT DEVELOPMENT STATUS AND OUTLOOK

9.1 India Glioblastoma Multiforme Treatment Market Size (2013-2018)
9.2 India Glioblastoma Multiforme Treatment Market Size and Market Share by Players (2013-2018)
9.3 India Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)

10 SOUTHEAST ASIA GLIOBLASTOMA MULTIFORME TREATMENT DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Glioblastoma Multiforme Treatment Market Size (2013-2018)
10.2 Southeast Asia Glioblastoma Multiforme Treatment Market Size and Market Share by Players (2013-2018)
10.3 Southeast Asia Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2018-2025)

11.1 Global Glioblastoma Multiforme Treatment Market Size (Value) by Regions (2018-2025)
  11.1.1 United States Glioblastoma Multiforme Treatment Revenue and Growth Rate (2018-2025)
  11.1.2 EU Glioblastoma Multiforme Treatment Revenue and Growth Rate (2018-2025)
  11.1.3 Japan Glioblastoma Multiforme Treatment Revenue and Growth Rate (2018-2025)
  11.1.4 China Glioblastoma Multiforme Treatment Revenue and Growth Rate (2018-2025)
  11.1.5 India Glioblastoma Multiforme Treatment Revenue and Growth Rate (2018-2025)
  11.1.6 Southeast Asia Glioblastoma Multiforme Treatment Revenue and Growth Rate (2018-2025)
11.2 Global Glioblastoma Multiforme Treatment Market Size (Value) by Type (2018-2025)
11.3 Global Glioblastoma Multiforme Treatment Market Size by Application (2018-2025)

12 GLIOBLASTOMA MULTIFORME TREATMENT MARKET DYNAMICS

12.1 Glioblastoma Multiforme Treatment Market Opportunities
12.2 Glioblastoma Multiforme Treatment Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Glioblastoma Multiforme Treatment Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Glioblastoma Multiforme Treatment Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global Glioblastoma Multiforme Treatment Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Glioblastoma Multiforme Treatment Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Glioblastoma Multiforme Treatment Market Share by Regions (2013-2018)
Figure United States Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure EU Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Glioblastoma Multiforme Treatment Revenue Market Share by Type in 2017
Figure Bevacizumab (Avastin) Market Size (Million USD) and Growth Rate (2013-2018)
Figure Carmustine (BiCNU) Market Size (Million USD) and Growth Rate (2013-2018)
Figure Temozolomide (Temodar and Temodal and Temcad) Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Glioblastoma Multiforme Treatment Market Share by Application in 2017
Figure Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate in Hospital (2013-2018)
Figure Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate in Clinic (2013-2018)
Figure Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate in Others (2013-2018)
Table Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2013-2018)
Figure Glioblastoma Multiforme Treatment Market Size Share by Players in 2013
Figure Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
Table AbbVie, Inc Basic Information List
Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of AbbVie, Inc (2013-2018)
Figure AbbVie, Inc Glioblastoma Multiforme Treatment Business Revenue Market Share (2013-2018)
Table Activartis GmbH Basic Information List
Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Activartis GmbH (2013-2018)
Figure Activartis GmbH Glioblastoma Multiforme Treatment Business Revenue Market Share (2013-2018)
Table Agenus Inc Basic Information List
Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Agenus Inc (2013-2018)
Figure Agenus Inc Glioblastoma Multiforme Treatment Business Revenue Market Share (2013-2018)
Table Arog Pharmaceuticals, Inc Basic Information List
Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Arog Pharmaceuticals, Inc (2013-2018)
Figure Arog Pharmaceuticals, Inc Glioblastoma Multiforme Treatment Business Revenue Market Share (2013-2018)
Table Bristol-Myers Squibb Company Basic Information List
Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Bristol-Myers Squibb Company (2013-2018)
Figure Bristol-Myers Squibb Company Glioblastoma Multiforme Treatment Business Revenue Market Share (2013-2018)
Table Cavion LLC Basic Information List
Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Cavion LLC (2013-2018)
Figure Cavion LLC Glioblastoma Multiforme Treatment Business Revenue Market Share (2013-2018)
Table Celldex Therapeutics Inc Basic Information List
Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Celldex Therapeutics Inc (2013-2018)
Figure Celldex Therapeutics Inc Glioblastoma Multiforme Treatment Business Revenue Market Share (2013-2018)
Table Cortice Biosciences Basic Information List
Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Cortice Biosciences (2013-2018)
Figure Cortice Biosciences Glioblastoma Multiforme Treatment Business Revenue Market Share (2013-2018)
Table Exelixis Inc Basic Information List
Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of Exelixis Inc (2013-2018)
Figure Exelixis Inc Glioblastoma Multiforme Treatment Business Revenue Market Share (2013-2018)
Table F. Hoffmann-La Roche Ltd. Basic Information List
Table Glioblastoma Multiforme Treatment Business Revenue (Million USD) of F. Hoffmann-La Roche Ltd. (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Glioblastoma Multiforme Treatment Business Revenue Market Share (2013-2018)
Table Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Product (2013-2018)
Figure Global Glioblastoma Multiforme Treatment Revenue Market Share (%) by Product (2013-2018)
Figure Global Glioblastoma Multiforme Treatment Market Share by Product in 2017
Table Global Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)
Figure Global Glioblastoma Multiforme Treatment Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Glioblastoma Multiforme Treatment
Figure United States Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2013-2018)
Figure United States Glioblastoma Multiforme Treatment Market Size Share by Players in 2013
Figure United States Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
Table United States Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)
Figure United States Glioblastoma Multiforme Treatment Revenue Market Share (%) by Application (2013-2018)
Figure United States Glioblastoma Multiforme Treatment Market Size Share by Application in 2017
Figure EU Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Table EU Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2013-2018)
Figure EU Glioblastoma Multiforme Treatment Market Size Share by Players in 2013
Figure EU Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
Table EU Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)
Figure EU Glioblastoma Multiforme Treatment Revenue Market Share (%) by Application (2013-2018)
Figure EU Glioblastoma Multiforme Treatment Market Size Share by Application in 2017
Figure Japan Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2013-2018)
Figure Japan Glioblastoma Multiforme Treatment Market Size Share by Players in 2013
Figure Japan Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
Table Japan Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)
Figure Japan Glioblastoma Multiforme Treatment Revenue Market Share (%) by Application (2013-2018)
Figure Japan Glioblastoma Multiforme Treatment Market Size Share by Application in 2017
Figure China Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Table China Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2013-2018)
Figure China Glioblastoma Multiforme Treatment Market Size Share by Players in 2013
Figure China Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
Table China Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)
Figure China Glioblastoma Multiforme Treatment Revenue Market Share (%) by Application (2013-2018)
Figure China Glioblastoma Multiforme Treatment Market Size Share by Application in 2017
Figure India Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Table India Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2013-2018)
Figure India Glioblastoma Multiforme Treatment Market Size Share by Players in 2013
Figure India Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
Table India Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)
Figure India Glioblastoma Multiforme Treatment Revenue Market Share (%) by Application (2013-2018)
Figure India Glioblastoma Multiforme Treatment Market Size Share by Application in 2017
Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Glioblastoma Multiforme Treatment Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size Share by Players in 2013
Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size Share by Players in 2017
Table Southeast Asia Glioblastoma Multiforme Treatment Market Size by Application (2013-2018)
Figure Southeast Asia Glioblastoma Multiforme Treatment Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Glioblastoma Multiforme Treatment Market Size Share by Application in 2017
Figure Global Glioblastoma Multiforme Treatment Market Size and Growth Rate (2018-2025)
Table Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Regions (2018-2025)
Figure Global Glioblastoma Multiforme Treatment Market Size Share (2018-2025)
Figure Global Glioblastoma Multiforme Treatment Market Size Share by Regions in 2025
Figure United States Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2018-2025)
Figure EU Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Type (2018-2025)
Figure Global Glioblastoma Multiforme Treatment Market Size Share by Type in 2018
Figure Global Glioblastoma Multiforme Treatment Market Size Share by Type in 2025
Table Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Application (2018-2025)
Figure Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Application in 2018
Figure Global Glioblastoma Multiforme Treatment Market Size (Million USD) by Application in 2025